Hypofractionated external beam radiotherapy to boost the prostate with ≥85 Gy/equivalent dose for patients with localised disease at high risk of lymph node involvement: feasibility, tolerance and outcome
Contributors
Zilli, Thomas; Jorcano, S; Escudé, L; Linero, D; Rouzaud, M; Dubouloz, A; Miralbell, RaymondPublished in
Clinical oncology, vol. 26, no. 6, p. 316-322Publication date
2014Abstract
UNIGE affiliation entities
UNIGE research groups
Citation (ISO format)
ZILLI, Thomas et al. Hypofractionated external beam radiotherapy to boost the prostate with ≥85 Gy/equivalent dose for patients with localised disease at high risk of lymph node involvement: feasibility, tolerance and outcome. In: Clinical oncology, 2014, vol. 26, n° 6, p. 316–322. doi: 10.1016/j.clon.2014.02.014
Main files (1)
Article (Published version)
Identifiers
- PID : unige:44334
- DOI : 10.1016/j.clon.2014.02.014
- PMID : 24667210
